Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-06 Sale |
2025-01-07 8:12 pm |
KALA BIO Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
5,779 | $7.63 | $44,094 | 379,576 (Direct) |
View |
| 2024-06-26 Sale |
2024-06-27 8:00 pm |
KALA BIO Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
15,168 | $4.75 | $72,048 | 263,755 (Direct) |
View |
| 2024-05-31 Sale |
2024-06-03 8:00 pm |
KALA BIO Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
7,392 | $6.09 | $45,017 | 278,923 (Direct) |
View |
| 2024-01-04 Sale |
2024-01-05 4:04 pm |
KALA BIO Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
4,539 | $6.73 | $30,547 | 350,815 (Direct) |
View |
| 2023-01-04 Sale |
2023-01-06 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
198 | $28.54 | $5,651 | 45,966 (Direct) |
View |
| 2022-10-26 Sale |
2022-10-28 4:15 pm |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
561 | $6.52 | $3,658 | 4,464 (Direct) |
View |
| 2022-06-27 Sale |
2022-06-29 8:09 pm |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
7,975 | $0.37 | $2,951 | 251,183 (Direct) |
View |
| 2022-01-04 Sale |
2022-01-05 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
9,518 | $1.3 | $12,373 | 1,034,158 (Direct) |
View |
| 2021-10-26 Sale |
2021-10-28 8:01 pm |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
27,598 | $1.8 | $49,676 | 268,676 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-29 5:25 pm |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
7,586 | $5.77 | $43,771 | 296,274 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-24 Option Award |
2025-02-26 9:57 pm |
N/A 2031-01-21 |
Q32 Bio Inc. | QTTB | Iwicki Mark T Director |
70,371 | $0 | 70,371 (Direct) |
View |
| 2025-02-21 Option Award |
2025-02-25 4:05 pm |
N/A 2035-02-14 |
Inhibikase Therapeutics Inc. | IKT | Iwicki Mark T Chief Executive Officer |
602,346 | $0 | 602,346 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 8:26 pm |
N/A 2035-02-14 |
Inhibikase Therapeutics Inc. | IKT | Iwicki Mark T Chief Executive Officer |
6,168,148 | $0 | 6,168,148 (Direct) |
View |
| 2025-01-06 Option Award |
2025-01-07 8:12 pm |
N/A 2035-01-05 |
KALA BIO Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
121,600 | $0 | 379,576 (Direct) |
View |
| 2024-06-08 Option Award |
2024-06-11 5:28 pm |
N/A 2034-06-07 |
Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 4:24 pm |
N/A 2034-06-05 |
Third Harmonic Bio Inc. | THRD | Iwicki Mark T Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 6:00 pm |
N/A 2034-06-04 |
Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2024-05-07 Option Award |
2024-05-09 4:30 pm |
N/A 2034-05-07 |
Merus N.V. | MRUS | Iwicki Mark T Director |
8,844 | $0 | 8,844 (Direct) |
View |
| 2024-03-25 Option Award |
2024-03-27 5:40 pm |
N/A 2034-03-24 |
Q32 Bio Inc. | QTTB | Iwicki Mark T Director |
25,534 | $0 | 25,534 (Direct) |
View |
Ownership |
2024-03-27 5:16 pm |
N/A 2031-01-21 |
Q32 Bio Inc. | QTTB | Iwicki Mark T Director |
0 | $0 | 44,837 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-05 4:04 pm |
N/A 2034-01-03 |
KALA BIO Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
78,800 | $0 | 350,815 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:39 pm |
N/A 2033-06-22 |
Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
370,704 | $0 | 488,385 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:16 pm |
N/A 2033-06-08 |
Merus N.V. | MRUS | Iwicki Mark T Director |
14,414 | $0 | 14,414 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 6:00 pm |
N/A 2033-06-05 |
Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:18 pm |
N/A 2033-06-05 |
Third Harmonic Bio Inc. | THRD | Iwicki Mark T Director |
16,250 | $0 | 16,250 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
71,715 | $0 | 117,681 (Direct) |
View |
| 2023-04-14 Exercise |
2023-04-17 08:26 am |
N/A 2023-06-02 |
Merus N.V. | MRUS | Iwicki Mark T Director |
73,576 | $0 | 73,576 (Direct) |
View |
| 2023-04-14 Exercise |
2023-04-17 08:26 am |
N/A N/A |
Merus N.V. | MRUS | Iwicki Mark T Director |
36,632 | $7.97 | 73,576 (Direct) |
View |
| 2023-04-14 Exercise |
2023-04-17 08:26 am |
N/A N/A |
Merus N.V. | MRUS | Iwicki Mark T Director |
36,944 | $6.57 | 73,576 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-15 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
1,512 | $0 | 1,512 (Direct) |
View |
| 2023-03-06 Option Award |
2023-03-08 5:02 pm |
N/A 2032-02-16 |
Third Harmonic Bio Inc. | THRD | Iwicki Mark T Director |
49,080 | $0 | 49,080 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-06 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
41,700 | $0 | 45,966 (Direct) |
View |
| 2022-10-26 Option Award |
2022-10-27 4:55 pm |
N/A 2032-10-25 |
Third Harmonic Bio Inc. | THRD | Iwicki Mark T Director |
13,667 | $0 | 13,667 (Direct) |
View |
Ownership |
2022-09-14 6:08 pm |
N/A N/A |
Third Harmonic Bio Inc. | THRD | Iwicki Mark T Director |
0 | $0 | 168,343 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 5:00 pm |
N/A 2032-06-20 |
Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:06 pm |
N/A 2032-06-01 |
Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-02 4:05 pm |
N/A 2032-05-31 |
Merus N.V. | MRUS | Iwicki Mark T Director |
16,604 | $0 | 16,604 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
775,000 | $0 | 1,034,158 (Direct) |
View |
| 2021-04-02 Option Award |
2021-07-01 6:33 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director |
158,497 | $0 | 158,497 (Direct) |
View |
Ownership |
2021-06-29 7:41 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director |
0 | $0 | 116,297 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:58 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2021-05-28 Option Award |
2021-06-02 4:10 pm |
N/A 2031-05-28 |
Merus N.V. | MRUS | Iwicki Mark T Director |
6,120 | $0 | 6,120 (Direct) |
View |
| 2021-01-28 Option Award |
2021-02-01 9:45 pm |
N/A 2031-01-28 |
Pulmatrix Inc. | PULM | Iwicki Mark T Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:50 pm |
N/A 2031-01-03 |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T Chief Executive Officer |
379,000 | $0 | 606,860 (Direct) |
View |